Search

Your search keyword '"Menendez-Gonzalez, M."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Menendez-Gonzalez, M." Remove constraint Author: "Menendez-Gonzalez, M."
40 results on '"Menendez-Gonzalez, M."'

Search Results

2. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

3. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

4. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

7. 20604. LA CLASIFICACIÓN MNCD CORRELACIONA MEJOR CON LA CALIDAD DE VIDA Y SITUACIÓN FUNCIONAL EN LOS PACIENTES CON ENFERMEDAD DE PARKINSON QUE EL HOEHN Y YAHR

8. 20279. TRIPLETES CAG EN EL GEN HTT Y SU RELACIÓN CON TAUOPATÍAS: EVIDENCIAS NEUROPATOLÓGICAS

9. New insights into the genetic etiology of Alzheimer's disease and related dementias

10. Using global team science to identify genetic parkinson's disease worldwide

11. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

12. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

13. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ¿4 Non-carriers

14. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

15. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE epsilon 4 Non-carriers

16. HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease

17. Moving beyond neurons:the role of cell type-specific gene regulation in Parkinson’s disease heritability

18. Using global team science to identify genetic parkinson's disease worldwide

19. Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer's disease.

21. Implementing a tridimensional diagnostic framework for personalized medicine in neurodegenerative diseases.

22. Targeting Soluble Amyloid Oligomers in Alzheimer's Disease: A Hypothetical Model Study Comparing Intrathecal Pseudodelivery of mAbs Against Intravenous Administration.

23. Therapeutic Challenges Derived from the Interaction Among Apolipoprotein E, Cholesterol, and Amyloid in Alzheimer's Disease.

24. Intrathecal Immunoselective Nanopheresis for Alzheimer's Disease: What and How? Why and When?

25. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

26. Erratum: Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies.

27. Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies.

28. C9orf72 , age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts.

29. Patients with Parkinson's Disease Show Alteration in their Visuospatial Abilities and in their Egocentric and Allocentric Spatial Orientation Measured by Card Placing Tests.

30. Albumin Exchange in Alzheimer's Disease: Might CSF Be an Alternative Route to Plasma?

31. Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer's Disease.

33. The Role of Innate Immune System Receptors in Epilepsy Research.

34. Vasomotor reactivity is similarly impaired in patients with Alzheimer's disease and patients with amyloid hemorrhage.

35. Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

36. Partial trisomy 13q22-qter associated to leukoencephalopathy and late onset generalised epilepsy.

38. Sodium chloride regulates Extracellular Regulated Kinase 1/2 in different tumor cell lines.

39. Hypertonicity activates GSK3beta in tumor cells.

40. Exacerbation of Lewy bodies dementia due to memantine.

Catalog

Books, media, physical & digital resources